| 摘要 |
The invention relates to medicine, in particular to hematology and can be used for determining the susceptibility of a person to the development of non-Hodgkin lymphoma.According to the invention, the method consists in the fact that persons in whom is determined the Arg/Arg genotype of the XRCC1 gene codon is additionally determined the ratio of IgM and IgG immunoglobulins and where the ratio is 0.03…0.24, it is established the person's susceptibility to the development of non-Hodgkin lymphoma. |
